Less than 6 hours of sleep, as well as durations of longer than 9 hours, are associated with a greater risk of heart attack, according to a new study.
Both insufficient (<6 hours) and longer (>9 hours) sleep durations are associated with greater risk of myocardial infarction (MI), according to a study published this week in the Journal of American College of Cardiology.
The prospective cohort analysis examined correlations between sleep duration and incident MI by utilizing Mendelian randomization (MR) to determine causality. Genetic risk of coronary artery disease (CAD) and joint effects with other sleep traits, such as insomnia, daytime napping, and sleep quality, were accounted for as well. Researchers aimed to not only determine the causal contribution of sleep to MI, but to assess its potential in mitigating genetic predisposition to CAD.
Self-reported sleep durations and medical records were derived from 461,347 UK Biobank participants aged 40 to 69 with no relevant cardiovascular disease:
Assessments revealed a stark multivariable-adjusted risk of incidence for MI in both patient groups reported shorter and longer sleep durations. Compared with patients who slept 6 to 9 hours a night, short sleepers had a significant 20% higher risk of incident MI (hazard ratio [HR], 1.20; 95% CI, 1.07-1.33), while longer sleepers exhibited a heightened 34% risk (HR,1.34; 95% CI, 1.13-1.58). For patients who reported short or long sleep durations, and have a high genetic risk (top 25%) for CAD, a 130% higher risk of MI (HR, 2.30; 95% CI, 1.88-2.82) was found when compared with patients with a low genetic risk who slept for the optimal amount of time—6 to 9 hours.
Senior study author Celine Vetter, PhD, assistant professor of Integrative Physiology at the University of Colorado Boulder, emphasized the correlation between sleep duration and CAD found in the study. “This provides some of the strongest proof yet that sleep duration is a key factor when it comes to heart health, and this holds true for everyone,” said Vetter. For patients who have a high genetic liability for CAD, optimal sleep duration mitigated MI risk by 18% (HR, 0.82; 95% CI, 0.68-0.998). This substantial difference in MI risk for patients with high genetic risk of CAD highlights the importance of achieving an optimal sleep duration.
“Just as working out and eating healthy can reduce your risk of heart disease, sleep can too,” said Vetter. Duration of sleep plays a vital role as a either too little or too much sleep can increase MI risk. The further one gets from the optimal window of sleep duration, the higher that risk becomes compared to optimal sleepers in the unadjusted model:
“This gives us even more confidence that there is a causal relationship here - that it is sleep duration, not something else, influencing heart health,” said Vetter. The authors noted that investigation of sleep extension to prevent MI may be warranted.
Reference
Daghlas I, Dashti HS, Lane J, et al. Sleep duration and myocardial infarction. [published online September 2, 2019]. Journal of the American College of Cardiology. doi: 10.1016/j.jacc.2019.07.022.
Elevated Stress Hyperglycemia Ratio Linked to Higher All-Cause Mortality After Cardiovascular Events
November 20th 2024Evidence highlights the predictive value of the stress hyperglycemia ratio for mortality risk in patients with acute myocardial infarction, ischemic stroke, and acute heart failure.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen